LifeSiteNews.com

Thursday February 26, 2004



Quick Summary of Canadian Stem Cell Bill C-6, Formerly C-13


SHARE: E-mail E-MAIL  Print PRINT     

OTTAWA, February 26, 2004 (LifeSiteNews.com) - With the possible imminent passage of the fatally flawed Reproductive Technologies in the Canadian Senate LifeSite provides below a simple point-form list of the complex bill's problems and good points.

Problem points:

1. Denies the humanity of the unborn child
2. Does not ban all forms of cloning
3. Encourages in vitro fertilization (test tube babies), to create more "spare" embryos for research
4. Allows the implantation of clones into artificial wombs and mandates the killing of cloned babies before birth
5. Allows doctors to perform in vitro fertilization for homosexuals and unmarried person
6. Allows experimentation on living and dead fetuses (creates a market for aborted fetuses)
7. Does NOT ban surrogate motherhood
8. Does not ban mixing human and animal genes, so allows for making hybrids
9. Allows parents to give permission to have their embryonic children used for experimentation
10. Does not restrict embryonic stem cell research in any way
11. Allows the harvesting of sperm and ova after death of the donor
12. After the bill passes, an un-elected regulatory agency can create new regulations with no oversight from Parliament


Good Points:

1. Bans paying wages directly to surrogate mothers for their "services" (however, does allow them to be "compensated" for lost wages from another job)
2. Bans paying for sperm and ova
3. Bans sale of embryos

Campaign Life Coalition is asking concerned Canadians to immediately call Canadian Senators asking them to defeat or substantially amend the bill.

For more detailed information on the bill see
http://www.lifesite.net/features/stemcellembryo/c-13reprotechbill.html

Back to Top Back to Top

SHARE: E-mail E-MAIL  Print PRINT     



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.